OPRX

OptimizeRx Corp. (OPRX) ESG Analysis Analysis (2026)

Invetso Score: 6.2/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

OPRX’s R&D intensity of 6.8% of revenue suggests some product-development discipline, but peers in digital health often disclose broader climate and resource programs.

The company’s asset-light leverage profile reduces direct environmental footprint versus manufacturing-heavy healthcare peers, yet it provides limited evidence of proactive emissions management.

No Tier 1 filing evidence was provided on energy use, emissions, or waste, so environmental positioning versus peers remains difficult to verify and likely average.

Environmental disclosure appears narrower than larger healthcare peers that typically report formal sustainability metrics, which constrains relative ESG strength despite low operational intensity.

Social

Score:

OPRX’s gross margin of 72.1% implies a software-like operating model that can support scalable patient access, but peer comparison is limited without outcome disclosures.

Stock-based compensation at 8.1% of revenue indicates meaningful employee alignment, though it can also signal retention pressure relative to more mature peers.

No provided evidence covers patient safety, data privacy, workforce turnover, or DEI, leaving key social risks under-assessed versus healthcare technology peers.

The company’s asset-light structure likely reduces direct labor and facility exposure versus service-heavy peers, but social disclosure depth appears insufficient for a stronger relative score.

Governance

Score:

Debt-to-equity of 0.15 and net debt to EBITDA of -0.30 indicate conservative balance-sheet governance, which is generally stronger than more levered peers.

R&D at 6.8% of revenue suggests capital is being directed toward product development, but peer-relative governance quality depends on disclosure of oversight and controls.

Stock-based compensation at 8.1% of revenue is manageable, yet without board, audit, and executive-compensation detail, governance strength cannot be rated as leading.

The absence of filing-based evidence on board independence, shareholder rights, and compliance processes keeps governance below stronger-disclosure peers in the healthcare sector.

Overall Score

Score:

OPRX shows a modestly favorable ESG profile versus peers, led by conservative leverage and an asset-light model, but limited disclosure prevents a stronger relative assessment.

Score Driver: Conservative Capital Structure

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on OptimizeRx Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →